- Zacks•2 years ago
On Apr 29, Zacks Investment Research upgraded BioMarin Pharmaceutical Inc. (BMRN) to Zacks Rank #1 (Strong Buy).
- Investor's Business Daily•2 years ago
BioMarin Pharmaceutical (BMRN) stock rose 11.5% to an all-time high Friday on heavy volume as speculation builds that the company could be the next big biotech takeout. The stock jumped as investment bank ...
- Insider Monkey•2 years agoBioMarin Pharmaceutical Inc. (BMRN) and Other Top New Picks of Healthcare-Focused Visium Asset Management
Jacob Gottlieb‘s Visium Asset Management has recently revealed its equity positions as of the end of the fourth quarter in a 13F filing with the Securities and Exchange Commission. We will take a closer look at the top five newly initiated positions, all of which seem to be in the healthcare sector, which is not
Requested symbol wasn't found
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
As of 3:59 PM EST. Market open.
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|